Structural and molecular basis for hyperspecificity of RNA aptamer to human immunoglobulin G

RNA

Volumn 14, Issue 6, 2008, Pages 1154-1163

  Miyakawa, Shin ^a,b   Nomura, Yusuke ^b,c   Sakamoto, Taiichi ^b,c   Yamaguchi, Yoshiki ^d,e   Kato, Koichi ^b,d,f   Yamazaki, Satoko ^a,b   Nakamura, Yoshikazu ^b,g  

^a RIBOMIC Inc   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c CHIBA INSTITUTE OF TECHNOLOGY   (Japan)

^d NAGOYA CITY UNIVERSITY   (Japan)

^e RIKEN   (Japan)

^f INSTITUTE FOR MOLECULAR SCIENCE   (Japan)

^g UNIVERSITY OF TOKYO   (Japan)

Author keywords

Antibody purification; Immunoglobulin G Fc domain; NMR chemical shift; Protein A; RNA aptamer

Indexed keywords

ANTIBODY; APTAMER; FC RECEPTOR; HUMAN IMMUNOGLOBULIN; IMMUNOGLOBULIN G; PROTEIN A; RNA;

ANIMAL EXPERIMENT; ARTICLE; BINDING SITE; CHEMICAL ANALYSIS; HUMAN; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PURIFICATION; RAT; RNA BINDING; RNA STRUCTURE;

AMINO ACID SEQUENCE; APTAMERS, NUCLEOTIDE; BASE SEQUENCE; BINDING SITES; BINDING, COMPETITIVE; CHROMATOGRAPHY, AFFINITY; HUMANS; IMMUNOGLOBULIN FC FRAGMENTS; IMMUNOGLOBULIN G; MOLECULAR SEQUENCE DATA; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; NUCLEIC ACID CONFORMATION; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, IGG; STAPHYLOCOCCAL PROTEIN A; SUBSTRATE SPECIFICITY;

EID: 44149123383     PISSN: 13558382     EISSN: 14699001     Source Type: Journal    
DOI: 10.1261/rna.1005808     Document Type: Article

References (37)

1. Abramoff, M.D., Magelhaes, P.J., and Ram, S.J. 2004. Image processing with imageJ. Biophotonics Int. 11: 36-42.
2. Blank, M., Weinschenk, T., Priemer, M., and Schluesener, H. 2001. Systematic evolution of a DNA aptamer binding to rat brain tumor microvessels. Selective targeting of endothelial regulatory protein pigpen. J. Biol. Chem. 276: 16464-16468.
3. 15NMR by enhanced heteronuclear spectroscopy. Chem. Phys. Lett. 69: 185-189.
4. Cromwell, M.E.M., Hilario, E., and Jacobson, F. 2006. Protein aggregation and bioprocessing. AAPS J. 8: E572-E579. doi: 10.1208/aapsj080366.
5. Deisenhofer, J. 1981. Crystallographic refinement and atomic models of a human Fc fragment and its complex with fragment B of protein A from Staphylococcus aureus at 2.9 and 2.8 Å resolution. Biochemistry 20: 2361-2370.
6. Elkak, A. and Vjiayalakshmi, M.A. 1991. Study of the separation of mouse monoclonal-antibodies by pseudobioaffnity chromatography using matrix-linked histidine and histamine. J. Chromatogr. 570: 29-41.
7. Ellington, A.D. and Szostak, J.W. 1990. In vitro selection of RNA molecules that bind specific ligands. Nature 346: 818-822.
8. Ellington, A.D. and Szostak, J.W. 1992. Selection in vitro of single stranded DNA molecules that fold into specific ligand-binding structures. Nature 355: 850-852.
9. Fahrner, R.L., Knudsen, H.L., Basey, C.D., Galan, W., Feuerhelm, D., Vanderlaan, M., and Blank, G.S. 2001. Industrial purification of pharmaceutical antibodies: Development, operation, and validation of chromatography processes. Biotechnol. Genet. Eng. Rev. 18: 301-327.
10. Fassina, G., Ruvo, M., Palombo, G., Verdoliva, A., and Marino, M. 2001. Novel ligands for the affinity-chromatographic purification of antibodies. J. Biochem. Biophys. Methods 49: 481-490.
11. Gagnon, P. 1996. Purification tools for monoclonal antibodies. Validated Biosystems, Tucson, AZ.
12. Gesteland, R.F., Cech, T.R., and Atkins, J.F 1999. The RNA world. Cold Spring Harbor Laboratory Press, New York.
13. Ghose, S., Allen, M., Hubbard, B., Brooks, C., and Cramer, S.M. 2005. Antibody variable region interactions with Protein A: Implications for the development of generic purification processes. Biotechnol. Bioeng. 92: 665-673.
14. Harris, L.J., Skaletsky, E., and McPherson, A. 1998. Crystallographic structure of an intact IgG1 monoclonal antibody. J. Mol. Biol. 275: 861-872.
15. Huse, K., Bohme, H.-J., and Scholz, G.H. 2002. Purification of antibodies by affinity chromatography. J. Biochem. Biophys. Methods 51: 217-231.
16. Kato, K., Sautes-Fridman, C., Yamada, W., Kobayashi, K., Uchiyama, S., Kim, H., Enokizono, J., Galenha, A., Kobayashi, Y., Fridman, W.H., et al. 2000. Structural basis of the interaction between IgG and Fcγ receptors. J. Mol. Biol. 295: 213-224.
17. Keefe, A.D. and Schaub, R.G. 2008. Aptamers as candidate therapeutics for cardiovascular indications. Curr. Opin. Pharmacol. 8: 1-6.
18. Klussmann, S. 2006. The aptamer handbook. WILEY-VCH, Weinheim, Germany.
19. Martin, W.L., West Jr., A.P., Gan, L., and Bjorkman, P.J. 2001. Crystal structure at 2.8 Å of an FcRn/heterodimeric Fc complex: Mechanism of pH-dependent binding. Mol. Cell 7: 867-877.
20. Matsumiya, S., Yamaguchi, Y., Saito, J., Nagano, M., Sasakawa, H., Otaki, S., Satoh, M., Shitara, K., and Kato, K. 2007. Structural comparison of fucosylated and nonfucosylated fc fragments of human immunoglobulin g1. J. Mol. Biol. 368: 767-779.
21. Miyakawa, S., Oguro, A., Ohtsu, T., Imataka, H., Sonenberg, N., and Nakamura, Y. 2006. RNA aptamers to mammalian initiation factor 4G inhibit cap-dependent translation by blocking the formation of initiation factor complexes. RNA 12: 1825-1834.
22. Nakajima, H., Kiyokawa, N., Katagiri, Y.U., Taguchi, T., Suzuki, T., Sekino, T., Mimori, K., Ebata, T., Saito, M., Nakao, H., et al. 2001. Kinetic analysis of binding between Shiga toxin and receptor glycolipid Gb3Cer by surface plasmon resonance. J. Biol. Chem. 276: 42915-42922.
23. Nakamura, Y. 2001. Molecular mimicry between protein and tRNA. J. Mol. Evol. 53: 282-289.
24. Ng, E.W., Shima, D.T., Calias, P., Cunningham Jr., E.T., Guyer, D.R., and Adamis, A.P. 2006. Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease. Nat. Rev. Drug Discov. 5: 123-132.
25. Ngo, T.T. and Khatter, N. 1990. Chemistry and preparation of affinity ligands useful in immunoglobulin isolation and serum-protein separation. J. Chromatogr. 510: 281-291.
26. Oguro, A., Ohtsu, T., Svitkin, Y.V., Sonenberg, N., and Nakamura, Y. 2003. RNA aptamers to initiation factor 4A helicase hinder cap-dependent translation by blocking ATP hydrolysis. RNA 9: 394-407.
27. Ohuchi, S.P., Ohtsu, T., and Nakamura, Y. 2006. Selection of RNA aptamers against recombinant transforming growth factor-β type III receptor displayed on cell surface. Biochimie 88: 897-904.
28. Pellecchia, M., Sebbel, P., Hermanns, U., Wuthrich, K., and Glockshuber, R. 1999. Pilus chaperone FimC-adhesin FimH interactions mapped by TROSY-NMR. Nat. Struct. Biol. 6: 336-339.
29. Porath, J., Maisano, F., and Belew, M. 1985. Thiophilic adsorption - a new method for protein fractionation. FEBS Lett. 185: 306-310.
30. Romig, T.S., Bell, C., and Drolet, D.W. 1999. Aptamer affinity chromatography: Combinatorial chemistry applied to protein purification. J. Chromatogr. B Biomed. Sci. Appl. 731: 275-284.
31. Sondermann, P., Huber, R., Oosthuizen, V., and Jacob, U. 2000. The 3.2 Å crystal structure of the human IgG1 Fc fragment-FcγRIII complex. Nature 406: 267-273.
32. Tsumoto, K., Umetsu, M., Kumagai, I., Ejima, D., Philo, J.S., and Arakawa, T. 2004. Role of arginine in protein refolding, solubilization, and purification. Biotechnol. Prog. 20: 1301-1308.
33. Tuerk, C. and Gold, L. 1990. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 249: 505-510.
34. Wiegand, T.W., Williams, P.B., Dreskin, S.C., Jouvin, M.H., Kinet, J.P., and Tasset, D. 1996. High affinity oligonucleotide ligands to human IgE inhibit binding to Fc ε receptor 1. J. Immunol. 157: 221-230.
35. Yamaguchi, Y., Nishimura, M., Nagano, M., Yagi, H., Sasakawa, H., Uchida, K., Shitara, K., and Kato, K. 2006. Glycoform-dependent conformational alteration of the Fc region of human immunoglobulin G1 as revealed by NMR spectroscopy. Biochim. Biophys. Acta 1760: 693-700.
36. Zhou, B. and Wang, B. 2006. Pegaptanib for the treatment of age-related macular degeneration. Exp. Eye Res. 83: 615-619.
37. Zuker, M. 2003. MFOLD web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res. 31: 3406-3415.